These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37246089)

  • 1. The Management of Relapsed or Refractory Waldenström's Macroglobulinemia.
    García-Sanz R; Tedeschi A
    Hematol Oncol Clin North Am; 2023 Aug; 37(4):727-749. PubMed ID: 37246089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed and refractory Waldenstrom Macroglobulinemia.
    Amaador K; Kersten MJ; Minnema MC; Vos JMI
    Leuk Lymphoma; 2023 Jan; 64(1):30-41. PubMed ID: 36282673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel agents in the treatment of Waldenström's macroglobulinemia.
    Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; O'Connor K; Nelson M; Patterson CJ; Ghobrial I
    Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S199-206. PubMed ID: 17877845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waldenstrom's macroglobulinemia in the era of immunotherapy.
    Vaxman I; Gertz M
    Leuk Lymphoma; 2020 Jun; 61(6):1292-1304. PubMed ID: 31960730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A safety profile of medications used to treat Waldenström's macroglobulinemia.
    García-Sanz R; Jiménez C; González De La Calle V; Sarasquete ME
    Expert Opin Drug Saf; 2018 Jun; 17(6):609-621. PubMed ID: 29768934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia.
    Kaedbey R; Forward N; Sehn LH; Shafey M; Doucette S; Chen CI
    Curr Oncol; 2022 Sep; 29(10):7122-7139. PubMed ID: 36290837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic algorithm of Waldenström's macroglobulinemia or lymphoplasmacytic lymphoma in Japan].
    Sekiguchi N
    Rinsho Ketsueki; 2021; 62(8):1139-1148. PubMed ID: 34497201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing complications secondary to Waldenström's macroglobulinemia.
    Pessach I; Dimopoulos MA; Kastritis E
    Expert Rev Hematol; 2021 Jul; 14(7):621-632. PubMed ID: 34170207
    [No Abstract]   [Full Text] [Related]  

  • 9. The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström's Macroglobulinemia.
    Khan AM
    J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current treatment options and investigational drugs for Waldenstrom's Macroglobulinemia.
    Gavriatopoulou M; Terpos E; Kastritis E; Dimopoulos MA
    Expert Opin Investig Drugs; 2017 Feb; 26(2):197-205. PubMed ID: 28043164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
    Dogliotti I; Jiménez C; Varettoni M; Talaulikar D; Bagratuni T; Ferrante M; Pérez J; Drandi D; Puig N; Gilestro M; García-Álvarez M; Owen R; Jurczak W; Tedeschi A; Leblond V; Kastritis E; Kersten MJ; D'Sa S; Kaščák M; Willenbacher W; Roccaro AM; Poulain S; Morel P; Kyriakou C; Fend F; Vos JMI; Dimopoulos MA; Buske C; Ferrero S; García-Sanz R
    Leukemia; 2023 Feb; 37(2):388-395. PubMed ID: 36435884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report.
    D'Aveni-Piney M; Divoux M; Busby-Venner H; Muller M; Broséus J; Feugier P
    J Med Case Rep; 2018 Jun; 12(1):164. PubMed ID: 29890999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is new in the treatment of Waldenstrom macroglobulinemia?
    Castillo JJ; Treon SP
    Leukemia; 2019 Nov; 33(11):2555-2562. PubMed ID: 31591468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib as a treatment option in patients with Waldenström macroglobulinemia.
    Dimopoulos MA; Chen C; Kastritis E; Gavriatopoulou M; Treon SP
    Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):110-7. PubMed ID: 20371443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
    Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
    J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenstrom's macroglobulinemia: Recent advances in biology and therapy.
    Neparidze N; Dhodapkar MV
    Clin Adv Hematol Oncol; 2009 Oct; 7(10):677-81, 687-90. PubMed ID: 20040909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients.
    D'Sa S; Matous JV; Advani R; Buske C; Castillo JJ; Gatt M; Kapoor P; Kersten MJ; Leblond V; Leiba M; Palomba ML; Paludo J; Qiu L; Sarosiek S; Shadman M; Talaulikar D; Tam CS; Tedeschi A; Thomas SK; Tohidi-Esfahani I; Trotman J; Varettoni M; Vos J; Garcia-Sanz R; San-Miguel J; Dimopoulos MA; Treon SP; Kastritis E
    Semin Hematol; 2023 Mar; 60(2):80-89. PubMed ID: 37147252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathology, diagnostics, and treatment of Waldenström's macroglobulinaemia].
    Holmström MO
    Ugeskr Laeger; 2011 Oct; 173(41):2557-60. PubMed ID: 21985832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.